Skip to main content

Animations

MJFF Publications

8691 - 8700 of 9145 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2019
  • 2019
  • 2024
  • 2024
  • 2019
  • Summary Details
    OPEN
    Title: An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s disease
    Journal Name: Frontiers in Cell and Developmental Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fcell.2024.1379984
    Citation Count: 8
  • Summary Details
    OPEN
    Title: SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s disease
    Journal Name: Frontiers in Pharmacology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fphar.2024.1477009
    Citation Count: 6
  • Summary Details
    OPEN
    Title: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkae776
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00805-z
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease
    Journal Name: Communications Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s43856-024-00630-8
    Citation Count: 9
  • Summary Details
    OPEN
    Title: miR-34a as hub of T cell regulation networks
    Journal Name: Journal for ImmunoTherapy of Cancer
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40425-019-0670-5
    Citation Count: 52
  • Summary Details
    OPEN
    Title: The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-019-1394-3
    Citation Count: 123
  • Summary Details
    OPEN
    Title: AccessPD as a next generation registry to accelerate Parkinson’s disease research
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00651-z
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00672-8
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Identification of N-linked glycans as specific mediators of neuronal uptake of acetylated α-Synuclein
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3000318
    Citation Count: 56
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.